Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome

Gorav Batra1,2, Anders Ahlsson3, Bertil Lindahl1,2

  • 1a Uppsala Clinical Research Center , Uppsala , Sweden.

Insights

Patients undergoing coronary artery bypass grafting (CABG) with atrial fibrillation (AF) face increased mortality and heart failure risks. Postoperative AF also elevates the risk of recurrent AF, highlighting the importance of managing this arrhythmia post-surgery.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Outcomes Research

Background:

  • Atrial fibrillation (AF) is a common comorbidity in patients undergoing cardiac surgery.
  • The impact of pre-existing and newly developed AF on outcomes after coronary artery bypass grafting (CABG) requires further elucidation.

Purpose of the Study:

  • To investigate the association between preoperative and postoperative atrial fibrillation (AF) and clinical outcomes in patients undergoing coronary artery bypass grafting (CABG).

Main Methods:

  • A cohort of 9,107 patients undergoing CABG between 2010 and 2013 was identified from the Swedish Heart Surgery Registry.
  • Outcomes including all-cause mortality, cardiovascular mortality, myocardial infarction, congestive heart failure, ischemic stroke, and recurrent AF were analyzed.
  • Adjusted Cox regression models were used to compare outcomes between patients with no AF, preoperative AF, and postoperative AF.

Main Results:

  • Preoperative AF (8.1%) was linked to significantly higher risks of all-cause mortality (HR 1.76), cardiovascular mortality (HR 2.43), and congestive heart failure (HR 2.21).
  • Postoperative AF (25.1%) was associated with increased risks of all-cause mortality (HR 1.27), cardiovascular mortality (HR 1.52), congestive heart failure (HR 1.47), and recurrent AF (HR 4.38).
  • Neither preoperative nor postoperative AF showed a significant association with myocardial infarction or ischemic stroke.

Conclusions:

  • Approximately one-third of CABG patients experienced either preoperative or postoperative AF.
  • Both pre- and postoperative AF significantly increase the risk of mortality and congestive heart failure following CABG.
  • Postoperative AF independently predicts a higher likelihood of recurrent AF, emphasizing the need for vigilant monitoring and management.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
471
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Amyloid Fibrils03:03

Amyloid Fibrils

6.4K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
273
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
383